Related Experiment Video

Updated: Aug 12, 2025

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

112.1K

Wnt3a is a promising target in colorectal cancer

Muhammad Tufail1, Changxin Wu2

  • 1Institute of Biomedical Sciences, Shanxi University, Taiyuan, 030006, China. mtufail0276@gmail.com.

Medical Oncology (Northwood, London, England)
|January 31, 2023
PubMed

Insights

Activated Wnt signaling drives most colorectal cancers (CRC). This review details Wnt3a

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Colorectal cancer (CRC) is a major global health concern, often driven by aberrant Wnt signaling.
  • Wnt ligands (Wnts) are crucial secreted glycoproteins for Wnt pathway function.
  • The diverse roles of 19 human Wnts in CRC development remain incompletely understood.

Purpose of the Study:

  • To review the canonical Wnt signaling pathway in colorectal cancer.
  • To specifically examine the expression patterns of Wnt3a in CRC.
  • To explore the association between Wnt3a, angiogenesis, and CRC progression, including inhibition strategies.

Main Methods:

  • Literature review of Wnt signaling in colorectal cancer.
  • Analysis of Wnt3a expression patterns and their correlation with CRC characteristics.
  • Investigation of Wnt3a inhibition as a therapeutic approach.

Main Results:

  • Activated Wnt signaling is a hallmark of most colorectal cancers.
  • Wnt3a expression is implicated in the angiogenesis and progression of CRC.
  • Inhibiting Wnt3a signaling presents a potential therapeutic avenue for CRC.

Conclusions:

  • A comprehensive understanding of Wnt ligands, particularly Wnt3a, is vital for CRC management.
  • Targeting Wnt3a signaling may offer a strategy to combat colorectal cancer.
  • Further research into Wnt biology is essential for advancing CRC treatment.
Keywords:
AngiogenesisChemoresistanceColorectal cancerWnt pathwayWnt3a

More Related Videos

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

35.2K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.8K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K